Onchilles Pharma
Chang Cui has been working in the scientific field since 2016. Chang began as a Ph.D. candidate at the Ben May Department for Cancer Research in 2016. In 2021, they became a Postdoctoral Researcher at the University of Chicago. Currently, they are a Senior Scientist and Scientist at Onchilles Pharma.
Chang Cui attended the University of Chicago from 2015 to 2020, where they obtained a Doctor of Philosophy (Ph.D.) in Cancer Biology. Prior to that, they attended Penn State University from 2011 to 2015 and earned a Bachelor of Science (Schreyer Honors Scholar) in Biochemistry and Molecular Biology (Major) and Nutritional Science (Minor).
This person is not in any offices
Onchilles Pharma
Onchilles Pharma was founded on breakthrough research of a novel neutrophil pathway that when activated selectively and comprehensively kills cancer cells.